Tort, Sera and Ciapponi, Agustín (2019) Clinical question: Does biomedical risk assessment help as an adjunct to smoking cessation interventions? Cochrane Clinical Answers, https://doi.org/10.1002/cca.2503.
External website: https://www.cochranelibrary.com/cca/doi/10.1002/cc...
Biomedical risk assessment (providing feedback on smoking‐related harm) as an adjunct to smoking cessation interventions may lead to more people stopping smoking at six months (on average, 151 vs 119 per 1000 people; moderate‐certainty evidence). In contrast, giving feedback on smoking‐related disease risk may result in fewer people quitting at six months (134 vs 168 per 1000 people; low‐certainty evidence). Giving feedback on smoking exposure seems to result in little to no difference in smoking cessation rates (moderate‐certainty evidence). RCT evidence seems to suggest that successful smoking cessation depends on the type of feedback given, but some evidence is of low certainty and only short‐term results are available. Consequently, no firm conclusions about biomedical risk assessment as an adjunct to smoking can be drawn.
HA Screening, identification, and diagnostic method > Physical / medical screening, assessment and diagnostic method
HJ Treatment or recovery method > Substance disorder treatment method > Cessation of tobacco use
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
J Health care, prevention, harm reduction and treatment > Patient / client care management
VA Geographic area > International
Repository Staff Only: item control page